**Question:** A new drug with in vitro activity against HIV is tested on a population of patients with Western-blot confirmed HIV infections, in Mumbai. Out of the 200 individuals in the patient population, 100 individuals are chosen by a lot to receive the drug. The drug, which is tasteless, is administered in a cup of orange juice; the other patients receive pure orange juice. Neither the nurses, doctors, nor patients know which patients receive the drug. At the end of the study period, the number of CD4+ T cells is determined for all of the subjects. What is the research method used in this study?

A. Randomized controlled trial
B. Observational study
C. Cross-sectional study
D. Case-control study

**Correct Answer:** A. Randomized controlled trial

**Core Concept:** The question describes a study in which patients with HIV are randomly assigned to receive either the experimental drug or placebo (in this case, orange juice). This is a randomized controlled trial (RCT), which is a standard gold standard method for assessing the efficacy of a new treatment or intervention.

**Why the Correct Answer is Right:** In an RCT, participants are randomly allocated to different groups to ensure that any observed effects are due to the treatment being tested, not other differences between the groups. By comparing the outcomes of the treatment group with the placebo group (in this case, the control group), the researchers can determine whether the drug has a significant effect on the number of CD4+ T cells in patients with HIV.

**Why Each Wrong Option is Incorrect:**

A. Observational study: This refers to studies that describe the relationship between variables without randomly assigning participants. In this question, patients are not randomly assigned, making option A incorrect.

B. Cross-sectional study: This type of study examines a single point in time, while the question involves a longitudinal study assessing the effects of the drug on CD4+ T cell count over time.

C. Cross-sectional study: This type of study investigates a single point in time, while the question involves a longitudinal study assessing the effects of the drug on CD4+ T cell count over time.

D. Case-control study: This study design compares cases (patients with a specific condition) with controls (individuals without that condition), while the question involves comparing a treatment group to a placebo group, not case-controls.

**Clinical Pearls:**

1. Randomized controlled trials (RCTs) are essential to evaluate the efficacy of a new treatment or intervention, such as the drug in this question. They minimize potential biases by randomly assigning participants to different groups and comparing the outcomes between these groups. This helps determine if the treatment has a significant effect on the number of CD4+ T cells, which is crucial for assessing the severity of HIV infection progression.
2. The study is longitudinal (following the patients over time) and assesses the drug's effect on CD4+ T cell count. This is essential for understanding how the treatment impacts the disease progression over time.
3. The study design is not a cross-sectional study, as cross-sectional studies evaluate data from a single point in time.
4. The study